Compensatory Equity Incentive Plan and Other Equity Incentives (Tables)

12 Months Ended

Jun. 30, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of share based compensation award plans

These plans are summarized below:

			Award Shares		Available for
			Outstanding		Issuance
	Award		at June 30,		at June 30,
Equity Compensation Arrangement	Authorized		2017		2017
Amended and Restated Omnibus Incentive Plan		3,915,625		2,604,968		631,701
Employee Stock Purchase Plan		400,000		—		377,988
		4,315,625		2,604,968		1,009,689

Schedule of stock options fair value assumptions

For stock options and restricted stock units (“RSUs”) granted in the years ended June 30, 2017 and 2016, the Company estimated the fair value of each stock award as of the date of grant using the following assumptions:

	Year ended June 30,
	2017		2016
Weighted average expected volatility	77% - 83%		68% - 103%
Dividend yields		0%		0%
Weighted average risk-free interest rate		1.24% - 1.90%		0.37% - 1.49%
Weighted average expected term, in years		7.49		4.29 - 7.50

Schedule of share-based payment awards activity

A summary of the activity for share-based payment awards in the years ended June 30, 2017 and 2016 is presented below:

	Stock Options						Restricted Stock Units (RSUs)
					Weighted	Weighted				Weighted
					Average	Average				Average
					Exercise	Remaining				Remaining
		Shares			Price	Contract		Shares		Contract
June 30, 2015		722,483		$	2.08	5.3		1,075,300		0.9
Granted		155,592		$	1.49	9.4		236,495		2.3
Exercised		(6,077	)	$	1.07	3.7		—		—
Cancelled/Forfeited		(52,738	)	$	3.26	—		—		—
June 30, 2016		819,260		$	1.90	5.6		1,311,795		0.9
Granted		346,926		$	1.63	9.4		230,772		2.3
Exercised		—			—	—		(33,785	)	—
Cancelled/Forfeited		(70,000	)	$	4.04	—		—		—
June 30, 2017		1,096,186		$	1.68	6.3		1,508,782		0.9
Awards exercisable/
vested as of
June 30, 2017		851,675		$	1.70	5.7		1,069,870		—
Awards unexercisable/
unvested as of
June 30, 2017		244,511		$	1.60	8.6		438,912		0.9
		1,096,186						1,508,782

Schedule of share-based compensation future cost to be recognized

The expected compensation cost to be recognized is as follows:

	Stock
	Options		RSUs		Total
Year ended June 30, 2018		40,004		244,917		284,921
Year ended June 30, 2019		19,088		144,984		164,072
Year ended June 30, 2020		5,197		29,989		35,186
Year ended June 30, 2021		2,105		—		2,105
	$	66,394	$	419,890	$	486,284

Summary of the number and weighted average grant date fair values regarding our unexercisable/unvested awards

The following table is a summary of the number and weighted average grant date fair values regarding our unexercisable/unvested awards as of June 30, 2017 and 2016 and changes during the two years then ended:

Unexercisable/unvested awards	Stock Options Shares		RSU Shares		Total Shares		Weighted-Average Grant Date Fair Values (per share)
June 30, 2015	224,500		403,870		628,370		$	1.10
Granted	155,592		236,495		392,087		$	1.39
Vested	(197,842	)	(198,766	)	(396,608	)	$	1.21
Cancelled/Forfeited	—		—		—			—
June 30, 2016	182,250		441,599		623,849		$	1.35
Granted	346,926		230,772		577,698		$	1.33
Vested	(275,915	)	(233,459	)	(509,374	)	$	1.28
Cancelled/Forfeited	(8,750	)	—		(8,750	)	$	1.02
June 30, 2017	244,511		438,912		683,423		$	1.39

Schedule of total stock-based compensation expense included in the consolidated statements of comprehensive income

The following table shows total stock-based compensation expense for the years ended June 30, 2017 and 2016 included in the Consolidated Statement of Comprehensive Income:

	Year ended June 30,
	2017		2016
Stock options	$	46,840	$	49,293
RSUs		348,035		299,442
Total	$	394,875	$	348,735
The amounts above were included in:
Selling, general & administrative	$	389,675	$	347,206
Cost of sales		3,876		316
New product development		1,324		1,213
	$	394,875	$	348,735